Statistics for [Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling
Total visits
| views | |
|---|---|
| [Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling | 218 |
Total visits per month
| views | |
|---|---|
| October 2023 | 0 |
| November 2023 | 0 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
File Visits
| views | |
|---|---|
| oncotarget-07-23608.pdf | 146 |
Top country views
| views | |
|---|---|
| United States | 147 |
| Germany | 15 |
| China | 6 |
| Ukraine | 6 |
| Russia | 4 |
| Canada | 2 |
| Italy | 2 |
| United Kingdom | 1 |
| Malaysia | 1 |
| Portugal | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 46 |
| Fairfield | 24 |
| Ann Arbor | 20 |
| Kiez | 13 |
| Houston | 10 |
| Cambridge | 9 |
| Jacksonville | 7 |
| Kiev | 6 |
| San Francisco | 4 |
| Saint Petersburg | 3 |
| Washington | 3 |
| Beijing | 2 |
| Brooklyn | 2 |
| Toronto | 2 |
| Grùmolo | 1 |
| Gunzenhausen | 1 |
| Linda-a-velha | 1 |
| Milan | 1 |
| Mountain View | 1 |
| Philadelphia | 1 |
| Scottsdale | 1 |
| Seattle | 1 |
| Seremban | 1 |
| Shenzhen | 1 |